Clinical trial
Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
NCT00226551 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00226551 |
|---|---|
| Title | Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms |
| Official title | ß2 Adrenergic Receptor Polymorphisms and Vasodilation of Internal Mammary Artery Induced by Isoproterenol |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Drug |
| Interventions | Isoproterenol |
| Enrollment | 100 |
| Start date | Aug 1, 1999 |
| First posted | Sep 27, 2005 |
| Last update posted | Oct 29, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: